Literature DB >> 22554960

Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.

Emad A Rakha1, May Tun, Enaam Junainah, Ian O Ellis, Andrew Green.   

Abstract

UNLABELLED: Encapsulated papillary carcinoma (EPC) of the breast is a distinct histological subtype characterised by malignant epithelial proliferation supported by fibrovascular stalks. Although EPC typically lacks myoepithelial cells, it shows indolent clinical course. The classification of EPC as an in situ, or invasive disease, remains a matter of debate.
METHODS: In this study, the authors investigated a panel of invasion-associated markers in a series of EPC and compared their expression with control groups of non-papillary ductal carcinoma in situ (DCIS) and conventional invasive carcinomas. The expression pattern of four matrix metalloproteinases (MMP-1, MMP-2, MMP-7 and MMP-9), transforming growth factor receptor beta, vascular endothelial growth factor (VEGF) and E-cadherin were assessed in the tumour cell and/or stromal tissue, and the results were analysed.
RESULTS: EPC showed higher expression levels of both MMP-1 and MMP-9 compared with DCIS, and no significant differences were observed between EPC and invasive carcinoma. Expression of MMP-2 and MMP-7 levels were similar in EPC and DCIS, but both showed lower levels compared with invasive tumours. EPC showed higher expression of E-cadherin and transforming growth factor receptor ß1 compared with both DCIS and invasive cancer. No difference in the stromal expression of MMPs or tumour expression of VEGF was detected.
CONCLUSION: EPC exhibits an expression pattern of invasion-associated markers, which is intermediate in nature between DCIS and invasive cancer, providing further support of the unique biological features of EPC, and which may explain its clinically indolent behaviour.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554960     DOI: 10.1136/jclinpath-2012-200710

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Intracystic papillary carcinoma of the breast: A SEER database analysis of implications for therapy.

Authors:  Harveshp Mogal; Doris R Brown; Scott Isom; Kayla Griffith; Marissa Howard-McNatt
Journal:  Breast       Date:  2016-04-04       Impact factor: 4.380

2.  Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases.

Authors:  Thaer Khoury; Qiang Hu; Song Liu; Jianmin Wang
Journal:  Mod Pathol       Date:  2013-08-02       Impact factor: 7.842

Review 3.  Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management.

Authors:  Emad A Rakha; Sunil Badve; Vincenzo Eusebi; Jorge S Reis-Filho; Stephen B Fox; David J Dabbs; Thomas Decker; Zsolt Hodi; Shu Ichihara; Andrew H S Lee; José Palacios; Andrea L Richardson; Anne Vincent-Salomon; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Ian O Ellis
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

Review 4.  Papillary neoplasms of the breast-reviewing the spectrum.

Authors:  Timothy Kwang Yong Tay; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2021-01-18       Impact factor: 7.842

5.  Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast.

Authors:  Salvatore Piscuoglio; Charlotte K Y Ng; Luciano G Martelotto; Carey A Eberle; Catherine F Cowell; Rachael Natrajan; François-Clement Bidard; Leticia De Mattos-Arruda; Paul M Wilkerson; Odette Mariani; Anne Vincent-Salomon; Britta Weigelt; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2014-06-26       Impact factor: 6.603

6.  Diagnosis, treatment, and outcomes of encapsulated papillary carcinoma: a single institution experience.

Authors:  Laura Steponavičienė; Daiva Gudavičienė; Rūta Briedienė; Donatas Petroška; Aušra Garnelytė
Journal:  Acta Med Litu       Date:  2018

7.  Encapsulated Papillary Carcinoma of Breast: Clinicopathological Features and Prognostic Parameters.

Authors:  Atif A Hashmi; Syeda N Iftikhar; Shahzeb Munawar; Arham Shah; Muhammad Irfan; Javaria Ali
Journal:  Cureus       Date:  2020-10-31

8.  Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers.

Authors:  Marjory Koller; Si-Qi Qiu; Matthijs D Linssen; Liesbeth Jansen; Wendy Kelder; Jakob de Vries; Inge Kruithof; Guo-Jun Zhang; Dominic J Robinson; Wouter B Nagengast; Annelies Jorritsma-Smit; Bert van der Vegt; Gooitzen M van Dam
Journal:  Nat Commun       Date:  2018-09-18       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.